摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲氧基-2,2-二甲基色满-4-酮 | 98910-61-3

中文名称
5-甲氧基-2,2-二甲基色满-4-酮
中文别名
——
英文名称
2,3-dihydro-5-methoxy-2,2-dimethyl-4H-1-benzopyran-4-one
英文别名
2,2-Dimethyl-5-methoxy-4-chromanone;2,2-dimethyl-5-methoxychroman-4-one;5-methoxy-2,2-dimethyl-4-chromanone;5-methoxy-2,2-dimethylchroman-4-one;5-methoxy-2,2-dimethyl-chroman-4-one;2,2-Dimethyl-5-methoxy-chromanon-(4);5-methoxy-2,2-dimethyl-3H-chromen-4-one
5-甲氧基-2,2-二甲基色满-4-酮化学式
CAS
98910-61-3
化学式
C12H14O3
mdl
——
分子量
206.241
InChiKey
RWFBDXQSHYXJRA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    124-125 °C
  • 沸点:
    330.1±41.0 °C(Predicted)
  • 密度:
    1.107±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2932999099
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H317,H319,H335

SDS

SDS:b2a70f19ccd073d379890fddf2686b2c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
    申请人:AbbVie S.à.r.l.
    公开号:US20180244640A1
    公开(公告)日:2018-08-30
    The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
    本发明涉及化合物及其在囊性纤维化治疗中的应用,其生产方法,包含相同化合物的药物组合物,以及通过给予本发明化合物治疗囊性纤维化的方法。
  • Fries rearrangement of methoxyphenyl 3-methylbut-2-enoates
    作者:F. Camps、J. Coll、O. Colomina、A. Messeguer
    DOI:10.1002/jhet.5570220229
    日期:1985.3
    Fries rearrangement of 2-, 3- and 4-methoxyphenyl 3-methylbut-2-enoates 3-5 in methanesulfonic acid, polyphosphoric acid, aluminum chloride and under photochemical conditions have been studied. The outcome of the reactions was determined by the substitution pattern in the starting products and the reaction conditions used. Under Lewis acid catalysis, acylation accounted for the major components of
    已经研究了在甲磺酸,多磷酸,氯化铝中和在光化学条件下2-,3-和4-甲氧基苯基3-甲基丁-2-烯酸酯3-5的薯条重排。反应的结果取决于起始产物中的取代方式和所用的反应条件。下路易斯酸催化,酰化占反应混合物的主要成分,导致茚满酮和2,3-二氢4的形成ħ分别-1-苯并吡喃-4-酮在的情况下ø -和米-酯3和5,而烷基化得到二氢香豆素是对酯5的优选途径。另一方面,在所有情况下,o-酰化是光化学重排中的主要反应过程。
  • Facile Deoxygenation of Hydroxylated Flavonoids by Palladium-Catalysed Reduction of its Triflate Derivatives
    作者:József Kövér、Sándor Antus
    DOI:10.1515/znb-2005-0716
    日期:2005.7.1

    An efficient procedure to deoxygenate hydroxy substituted flavonoids, isoflavonoids and related compounds via their trifluoromethanesulfonates is presented. Their reduction with formic acid in the presence of a catalytic amount of palladium acetate, triethylamine and 1,3-bis(diphenylphosphanyl) propane (dppp) in DMF results in their des-hydroxy derivatives without affecting other functional groups.

    通过使用三氟甲磺酸盐,以催化量的乙酸钯、三乙胺和1,3-双(二苯基膦基)丙烷(dppp)在DMF中,将含羟基的黄酮类化合物、异黄酮类化合物及相关化合物脱氧的高效程序被提出。在甲酸存在下,它们的还原会导致它们的去羟基衍生物,而不影响其他功能团。
  • Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
    申请人:AbbVie S.à.r.l.
    公开号:US10428017B2
    公开(公告)日:2019-10-01
    The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
    本发明涉及治疗囊性纤维化的化合物及其用途、生产方法、包含本发明化合物的药物组合物,以及通过施用本发明化合物治疗囊性纤维化的方法。
  • Modification of Hydroxybenzopyranoids: Facile Deoxygenation of 2,2-Dimethyl-7-hydroxy-4-chromanones and a New Approach to Their Novel Mercapto Analogs
    作者:Peter Sebok、Tibor Timar、Tibor Eszenyi、Tamas Patonay
    DOI:10.1021/jo00100a038
    日期:1994.10
    A facile deoxygenation of a systematic series of substituted 2,2-dimethyl-7-hydroxy-4-chromanones via their sulfonate, isourea, and thiocarbamate derivatives is reported. The synthesis of novel 2,2-dimethyl-7-mercapto-4-chromanones has been accomplished by the hydrolysis of the corresponding thiocarbamates. The scope and limitations of different deoxygenation procedures in the case of these hydroxybenzopyranoids are also presented.
查看更多